(38830068) Recently, there has been a trend towards using higher maintenance doses, with 1.5 grams q12 being used initially for most patients in status epilepticus
Compared to placebo, GLP1-RAs reduced major adverse cardiovascular events without effect modification by SGLT2 inhibitor use (HR: 0.77
It is important to note that higher-dose semaglutide (2.4 mg, marketed as Wegovy) is licensed specifically for weight management in obesity and has separate eligibility criteria and dosing from the diabetes indication
Prescription and usage barriers are decreased by strong clinical familiarity
Short-term cold acclimation improves insulin sensitivity in patients with type 2 diabetes mellitus
Combining the previously observed binding sites for ET, RAS, and ANP in the ovary, we propose here a functional regulatory role of the ERAANPS (endothelin-renin-angiotensin system) in the ovary